Shenzhen, China, 15 August 2024 – MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technologies that drive innovation in life science, has been awarded the prestigious Red Dot Design Award for its groundbreaking high-throughput sequencer, DNBSEQ-T20×2 (“T20”). This recognition celebrates the exceptional design and innovation integral to the development of this groundbreaking technology.
The T20, powered by MGI DNBSEQ™ technology and introduced in 2023, is known for its breakthrough in reducing the cost of whole-genome sequencing to below $100, with the capacity to process up to 50,000 samples per year. This achievement sets a new global record in sequencing instrument throughput and individual sequencing cost reduction without compromising quality, earning it the reputation of a “Super Sequencing Factory” within the industry, transforming the landscape of genetic research and accelerating discoveries and medical advancements.
Following its launch, the T20 has garnered numerous accolades from prestigious industrial organisations worldwide, including the Globee® Awards for Medical Equipment and the BEYOND Healthcare Innovation Award in 2023, as well as the 2024 iF Design Award.
The Red Dot Award is an internationally recognised seal of quality for outstanding design, recognising products for their high levels of innovation, functionality and aesthetics. MGI Tech’s T20 was selected for this prestigious honour from a competitive pool of entries, reaffirming its position as a game-changer in the field of genetic sequencing. The jury of the Red Dot Award gave high praise for the design of the DNBSEQ-T20×2, saying, “The individual modules of the DNBSEQ-T20×2 are perfectly coordinated, both technologically and visually.”
Duncan Yu, President of MGI, expressed his pride in receiving the Red Dot Design Award for the T20 gene sequencing platform, stating, “The DNBSEQ-T20×2 represents a paradigm shift in genomics technology. Its ability to deliver high-quality sequencing results at an affordable cost opens up new horizons for personalised medicine, population studies, disease research and more. We are honoured to receive the Red Dot Design Award, which validates our dedication to delivering innovative, high-performance solutions to the scientific community.”
More information about the DNBSEQ-T20×2 platform can be found here.
